viernes, 7 de mayo de 2021

Study assesses the rate of rare blood clots in adults receiving Oxford-AstraZeneca vaccine

Study assesses the rate of rare blood clots in adults receiving Oxford-AstraZeneca vaccine

No hay comentarios:

Publicar un comentario